Virtu Financial’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,712
| Closed | -$239K | – | 1307 |
|
|
2024
Q2 | $239K | Sell |
14,712
-700
| -5% | -$11.4K | 0.02% | 654 |
|
|
2024
Q1 | $285K | Buy |
+15,412
| New | +$285K | 0.02% | 633 |
|
|
2022
Q3 | – | Sell |
-15,354
| Closed | -$216K | – | 1666 |
|
|
2022
Q2 | $216K | Buy |
+15,354
| New | +$216K | 0.02% | 730 |
|
|
2022
Q1 | – | Sell |
-44,980
| Closed | -$1.05M | – | 1440 |
|
|
2021
Q4 | $1.05M | Buy |
+44,980
| New | +$1.05M | 0.11% | 182 |
|
|
2021
Q3 | – | Sell |
-47,189
| Closed | -$1.15M | – | 1440 |
|
|
2021
Q2 | $1.15M | Buy |
+47,189
| New | +$1.15M | 0.11% | 166 |
|
|
2020
Q3 | – | Sell |
-12,285
| Closed | -$595K | – | 988 |
|
|
2020
Q2 | $595K | Buy |
+12,285
| New | +$595K | 0.07% | 315 |
|
|
2019
Q4 | $881K | Sell |
20,601
-25,513
| -55% | -$1.09M | 0.09% | 257 |
|
|
2019
Q3 | $1.66M | Buy |
+46,114
| New | +$1.66M | 0.13% | 148 |
|
|
2019
Q2 | – | Sell |
-18,727
| Closed | -$503K | – | 1400 |
|
|
2019
Q1 | $503K | Sell |
18,727
-4,248
| -18% | -$114K | 0.03% | 545 |
|
|
2018
Q4 | $372K | Buy |
+22,975
| New | +$372K | 0.02% | 615 |
|